SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines ...
Atrasentan demonstrated mean proteinuria reductions of 38.1% proteinuria at six weeks of treatment, 48.3% at 12 weeks of treatment and 54.7% at 24 weeks of treatment There were no meaningful changes ...
In a recent study published in PLoS ONE, researchers assessed the binding of Galanthus nivalis agglutinin to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Study: Removal of ...
NEW YORK--(BUSINESS WIRE)--Affinity Solutions, a global insights firm, commissioned Forrester Consulting to conduct a study evaluating organizations’ readiness for data deprecation across digital ...
Boomers are the key drivers of QSR sales, according to a recent Affinity study. The company’s most recent report was compiled from data collected from January 2021 through January 2024 utilizing ...
A team of scientists from China has recently deciphered the structural basis of comparatively higher binding affinity of two Omicron sub-variants, namely B.1.1 and B.2, for human ...
CHARLOTTE, N.C., June 19, 2025 /PRNewswire/ -- Affinity Group is proud to present the 2025 Operator Path to Purchase Study, a comprehensive look at the evolving factors influencing foodservice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback